The diabetes drug Mounjaro will be tested alongside an experimental treatment to study how to maintain muscle mass while losing weight, according to an announcement Thursday—after earlier studies ...

Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the ...

A widely used weight-loss drug may have an unexpected side effect, especially for women and older adults. New research ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and acute kidney failure. However, there have been limitations in directly ...

University of Utah Health researchers have discovered that Metformin, a common drug that’s been used in diabetes treatment for more than half a century, has surprising applications on a cellular level ...

(Reuters) -Fulcrum Therapeutics said on Thursday its experimental drug to treat a type of muscle disorder failed to meet the main goal in a late-stage study, sending the company's shares down nearly ...

A common drug used to treat diabetes may help the elderly bounce back faster from muscle injury or illness. Researchers at University of Utah Health discovered that Metformin can prevent muscle ...

Metformin's anti-senescent properties have been demonstrated through pre-clinical studies. To test the intervention in humans, the team recruited 20 healthy male and female older adults for a ...